期刊文献+

甘精胰岛素联合口服降糖药治疗2型糖尿病1例 被引量:1

下载PDF
导出
摘要 1例2型糖尿病患者使用口服降糖药物治疗血糖控制不佳,且BMI 29. 4kg/m^2,加用甘精胰岛素治疗3个月,指尖血糖由13. 2mmol/L降至6. 5mmol/L,糖化血糖蛋白由8. 9%降至7. 3%。患者监测餐后2小时指血血糖12~15mmol/l,加用沙格列汀5mg qd治疗4个月。后监测空腹指血血糖5~7mmol/L,餐后2小时指血血糖7~10mmol/L,复查糖化血红蛋白7. 3%。体重由83kg降至80kg,无不良反应和低血糖发生,结论:口服降糖药控制不佳的2型糖尿病患者,调整为甘精胰岛素联合口服降糖药后可有效控制血糖,且6月体重无增加。
作者 吴清
出处 《实用糖尿病杂志》 2018年第6期64-65,共2页 Journal of Practical Diabetology
  • 相关文献

参考文献3

二级参考文献20

  • 1Rosenstock J, Davies M, Home PD, et al. A randomized, 52- week, treat-to target trial comparing insulin detemir with insu- lin glargine when administered as added-on, to glucose-lowering drugs in insulin-na? ve people with type 2 diabetes. Diabetolo- gia, 2008, 51:408-416.
  • 2Klein O, Lynge J, Endahl L, et al. Albumin-bound basal insu- lin analogues (insulin detemir and NN344) : comparable time- action profiles but less variability than insulin glarine in type 2 diabetes. Diabetes Obes,Meteb, 2007, 9: 290-299.
  • 3Hallschmid M, Jauch-Chara K, Korm O, et al. Euglycemic in- fusion of insulin detemir compared with human insulin appears to increase direct current brain potential response and reduces food intake while inducing similar systemic effects. Diabetes, 2010,59 : 11.01-1107.
  • 4Bohm A, Staiger H, Hennige AM, et al. Effect of insulin det- emir, compared to human insulin, on 3T3-L1 adipogenesis. Regul Pept, 2008,151 : 160-163.
  • 5Holman RR,Paul SK,Bethel MA. 10-year follow-up of intensive glucose control in type 2 diabetes[J].New England Journal of Medicine,2008.1577-1589.
  • 6Nathan DM,Buse JB,Davidson MB. Management of hyperglycemia in type 2 diabetes:a consensus algorithm for the initiation and adjustment of therapy:a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes[J].Diabetes Care,2006.1963-1972.
  • 7Cobitz AR,Ambery P. Medical management of hyperglycemia in type 2 diabetes:a consensus algorithm for the initiation and adjustment of therapy:a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes[J].Diabetes Care,2009.e58.
  • 8Riddle MC,Rosenstock J,Gerich J. The treat-to-target trial:randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients[J].Diabetes Care,2003.3080-3086.
  • 9Swinnen SG,Dain MP,Aronson R. A 24-week,randomized,treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs[J].Diabetes Care,2010.1176-1178.
  • 10Cook MN,Girman C J,Stein PP. Glycemic control continues to deteriorate after sulphonylureas are added to metformin among patients with type 2 diabetes[J].Diabetes Care,2005.995-1000.

共引文献96

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部